D-0219-2025 Class II Ongoing
FDA drug recall D-0219-2025 was initiated by SKY PACKAGING on Jan 24, 2025 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 12, 2025
- Initiation Date
- Jan 24, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide within the United States
Code information
Lot #: 0000127312, Exp. Date 31-Mar-2025; 0000127576, 0000127577, Exp. Date 31-Jul-2025; 0000128204, Exp. Date 31-Dec-2025; 0000128358, Exp. Date 31-Jan-2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0219-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026